NHS Grampian has officially launched a specialist clinic focused on treating patients who have developed bladder damage as a result of ketamine use. The condition, often referred to as 'ketamine bladder syndrome,' involves severe inflammation and scarring of the bladder wall, which can lead to chronic pain, urinary frequency, and, in advanced cases, the need for surgical intervention or bladder removal.

While the announcement highlights the clinical response to this health issue, it does not detail the specific treatment protocols or the expected patient volume the clinic will manage. The establishment of this facility reflects a growing recognition within the healthcare system of the physical toll that recreational ketamine use can take on the urinary tract. Medical experts have long warned that chronic use of the drug can cause the bladder lining to become ulcerated and thickened, significantly reducing its capacity to hold urine.

This development is part of a broader effort to address the health consequences of substance misuse. By centralizing care, NHS Grampian aims to provide more specialized expertise for a condition that is often difficult to manage in general practice settings. The clinic's opening serves as a practical response to the increasing number of patients presenting with these specific urological symptoms, though the report remains limited in scope regarding the wider context of addiction services or prevention strategies.